Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The study investigates the utility of heart fatty-acid binding protein (H-FABP) in distinguishing TIA from mimics. Data from 175 patients from the StrokeChip multicenter study was retrospectively analyzed. H-FABP level was measured using a rapid point-of-care test. Findings revealed that H-FABP levels were higher in individuals with TIA compared to mimics [3.10 ng/mL (IQR 2.13-4.78) vs. 1.70 ng/mL (IQR 1.23-2.38)] (p < 0.001). The diagnostic performance of H-FABP, assessed using the area under the curve operating characteristic curve (AUC) was 0. 83 (95% CI = 0.76-0.90) for the final model, indicating good discriminative ability. The PanelomiX determined that a combined cutoff of > 1.85 ng/ml for H-FABP, age > 42.5 years, and baseline NIHSS > 3.5 had a 100% of sensitivity and 23.30% of specificity. The study suggests that H-FABP has potential as a TIA diagnostic biomarker. The rapid application of POCT's for H-FABP measurement supports its potential use in emergency departments and primary care settings.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s12265-024-10552-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reduction in within-litter variation of piglet birth weight through dietary supplementation of 3-hydroxyisobutyric acid in sows.
Front Vet Sci
August 2025
College of Animal Science and Technology, Henan University of Animal Husbandry and Economy, Zhengzhou, China.
Within-litter variations in birth weight (BW) influence piglet postnatal growth and survival rate. The present study investigated the effects of the valine metabolite 3-hydroxyisobutyric acid (3-HIB) on the birth weight of piglets by supplementing the sow diet with 3-HIB during late pregnancy. Forty sows were assigned randomly to the control (Con) group and 3-HIB supplementation groups (15 mg/kg body weight), with 20 sows per group.
View Article and Find Full Text PDFSystematic characterization of cell type-specific master metabolic regulators in Alzheimer's disease.
Res Sq
August 2025
Cleveland Clinic Genome Center, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH 44195, USA.
Alzheimer's disease (AD) exhibits metabolic heterogeneity; yet, the consequences on metabolic dynamics in a cell-type-specific manner and the underlying metabolite-sensor network basis remain unclear. Here, we show that neurons exhibit a striking decrease in energy and lipid-related metabolic activity, contrasted by an increase in microglial metabolism associated with neuroinflammation. To identify brain cell-type specific master metabolic regulators underlying the metabolic alterations of AD, we introduce scFUMES (ingle ell nctional tabolite-ensor), an algorithm integrating single-cell RNA sequencing, interactomics (protein-protein interactions), genomics, transcriptomics, and metabolomics from large human brain biobanks.
View Article and Find Full Text PDFDynamics of the Novel Cardiac Biomarkers sST2, H-FABP, GDF-15 and suPAR in HFrEF Patients Undergoing Heart Failure Therapy, a Pilot Study.
J Clin Med
August 2025
Department of Internal Medicine II, Paracelsus Medical University, 5020 Salzburg, Austria.
Despite improvements in medical therapy, heart failure with reduced ejection fraction (HFrEF) is a major burden on the healthcare system and remains a leading cause of death with a 5-year mortality rate of more than 60%. Novel therapeutic agents such as angiotensin-receptor-neprilysin-inhibitors (ARNIs) lead to significant improvement in clinical outcomes. Optimal therapy monitoring under these novel drugs is crucial for improving the outcome.
View Article and Find Full Text PDFA novel rapid rule-out protocol for acute chest pain using H-FABP point-of-care testing.
Sci Rep
August 2025
Clinic of Internal Medicine II, Department of Cardiology, Paracelsus Medical University of Salzburg, Müllner Hauptstraße 48, Salzburg, 5020, Austria.
Emergency department (ED) visits have gradually increased throughout recent years, contributing to the widespread problem of ED overcrowding. The purpose of this study was to develop a rapid rule-out strategy for patients with acute chest pain that integrates clinical characteristics and Heart-type fatty acid binding protein (H-FABP) to improve ED patient care. H-FABP point-of-care test results of 130 patients were integrated into a modified HEART score, with a score ≤ 3 points indicating rule-out of acute coronary syndrome (ACS).
View Article and Find Full Text PDF[Research progress on the biomarkers of sepsis-induced cardiomyopathy].
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
June 2025
Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, Guangdong, China.
Sepsis constitutes one of the principal causes of death globally, and the mortality rate of patients complicated with sepsis-induced cardiomyopathy (SIC) surges by over 50%. Early identification of patients with sepsis, particularly SIC, and implementing clinical intervention are vital measures to reduce the mortality. In recent years, biomarkers for the diagnosis and prognosis of SIC have emerged rapidly.
View Article and Find Full Text PDF